Day: January 17, 2024

CPR Cell Phone Repair is delighted to announce the opening of a new store, CPR Cell Phone Repair Laurel, in Laurel, Maryland. This store, owned by Malav Patel, extends CPR’s footprint in Maryland, offering top-tier electronic repair services to the Laurel community.

LAUREL, MD / ACCESSWIRE / January 17, 2024 / CPR Cell Phone Repair, a leader in the electronics repair industry, is proud to announce the opening of a new store, CPR Cell Phone Repair Laurel, located at 14440 Cherry Lane Ct, Suite 115, Laurel, MD, 20707. Under the ownership of Malav Patel, the store is set to offer a comprehensive range of repair services for electronics such as cell phones, laptops, gaming systems, digital music players, tablets, and other personal electronic devices.

CPR Laurel provides the local community with expert repair services for common issues like cracked screens, battery replacements, software malfunctions, and more complex technical repairs. The store’s team of skilled technicians is committed to offering efficient, reliable, and quality repair solutions synonymous with the CPR brand.

"I am excited to bring CPR’s trusted and professional repair services to the people of Laurel," said Malav Patel, owner of CPR Cell Phone Repair Laurel. "Our focus is on delivering exceptional customer service and high-quality repairs, ensuring our customers have access to convenient and reliable electronic repair solutions."

CPR Laurel operates from Monday to Saturday, 10:00 AM to 7:00 PM. Customers can reach the store for inquiries or to schedule a repair at 301-830-1897 or via email at laurel@cpr-stores.com. More information about the services offered can be found on the store’s website at https://www.cellphonerepair.com/laurel-md/.

About CPR Cell Phone Repair

CPR by Assurant (CPR), ranked the no. 1 franchise for electronics repairs in Entrepreneur magazine’s Franchise 500, is one of the largest, fastest-growing mobile repair franchises in North America, operating over 500 locations internationally. As a pioneer and leader in the electronics repair industry, CPR offers same-day repair and refurbishing services for cell phones, laptops, gaming systems, digital music players, tablets, and other personal electronic devices. Founded in Orlando, Fla. in 1996, CPR is owned by Assurant, Inc. (NYSE: AIZ). For more information about CPR by Assurant, visit www.cellphonerepair.com.

Media Contact

Chris Jourdan
chris.jourdan@cpr-corporate.com
877-392-6278 ext. 7711

SOURCE: CPR Cell Phone Repair

View the original press release on accesswire.com

VANCOUVER, BC / ACCESSWIRE / January 17, 2024 / Guanajuato Silver Company Ltd. (the "Company" or "GSilver") (TSXV:GSVR)(OTCQX:GSVRF) is pleased to announce commencement of a relationship with a Mexican silver mining company to process a portion of its surface inventory of mineralized material at Guanajuato Silver’s wholly owned El Cubo mines complex located in Guanajuato, Mexico.

Guanajuato Silver’s Chairman & CEO, James Anderson said, "We are excited to have reached this agreement which will utilize a considerable amount of the excess capacity that exists at our El Cubo mill. We believe both parties will mutually benefit from this agreement, as we collectively look to expand silver production in the Guanajuato area through the processing of low-cost and readily available material. With additional unutilized capacity still available at El Cubo, we continue to pursue similar business agreements with other mining groups in the area."

This material has been demonstrated compatible with the El Cubo processing circuit through comprehensive metallurgical testing; the first silver and gold concentrates from this processing agreement are expected to be generated prior to the end of January 2024.

About Guanajuato Silver
GSilver is a precious metals producer engaged in reactivating past producing silver and gold mines in central Mexico. The Company produces silver and gold concentrates from the El Cubo Mine Complex, Valenciana Mines Complex, and the San Ignacio mine; all three mines are located within the state of Guanajuato, which has an established 480-year mining history. In addition, the Company produces silver, gold, lead, and zinc concentrates from the Topia mine in northwestern Durango. With four operating mines and three processing facilities, Guanajuato Silver is one of the fastest growing silver producers in Mexico.

Technical Information
Hernan Dorado Smith (Qualified Professional – MMSA), a director and officer of GSilver and a "qualified person" as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects, has approved the scientific and technical information contained in this news release.

ON BEHALF OF THE BOARD OF DIRECTORS
"James Anderson"
Chairman and CEO

For further information regarding Guanajuato Silver Company Ltd., please contact:

JJ Jennex, Gerente de Comunicaciones, T: 604 723 1433
E: jjj@GSilver.com
Gsilver.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains certain forward-looking statements and information, which relate to future events or future performance including, but not limited to, the benefit from the agreement announced in this press release, expansion of silver production in the Guanajuato area through the processing of low-cost and readily available material, unutilized capacity still available at El Cubo, the pursuit of similar business agreements with other mining groups in the area, the amount of tonnes of additional material to be processed at the El Cubo mill on a monthly basis, the expected timeline to generate the first silver and gold concentrates from this processing agreement, and the Company’s status as one of the fastest growing silver producers in Mexico.

Such forward-looking statements and information reflect management’s current beliefs and expectations and are based on information currently available to and assumptions made by the Company; which assumptions, while considered reasonable by the Company, are inherently subject to significant operational, business, economic and regulatory uncertainties and contingencies. These assumptions include: our estimates of mineral resources and other mineralized material at El Cubo and the Company’s other mining projects in Guanajuato, Mexico and the assumptions upon which they are based, including geotechnical and metallurgical characteristics of rock conforming to sampled results and metallurgical performance; available tonnage of mineralized material to be mined and processed; resource grades and recoveries; assumptions and discount rates being appropriately applied to the 2023 Preliminary Economic Assessment on El Cubo ("2023 PEA"); the ability of the Company to ramp up processing of mineral resources and material at El Cubo and the Company’s other mining projects at the projected rates and source sufficient high grade mineralized material to fill such processing capacity; prices for silver, gold and other metals remaining as estimated; currency exchange rates remaining as estimated; availability of funds for the Company’s projects and to satisfy current liabilities and obligations including debt repayments; capital cost estimates; operating costs; decommissioning and reclamation estimates; prices for energy inputs, labour, materials, supplies and services (including transportation) and inflation rates remaining as estimated; no labour-related disruptions; no unplanned delays or interruptions in scheduled construction and production; all necessary permits, licenses and regulatory approvals are received in a timely manner; and the ability to comply with environmental, health and safety laws. The foregoing list of assumptions is not exhaustive.

Readers are cautioned that such forward-looking statements and information are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results, level of activity, production levels, performance or achievements of GSilver to differ materially from those expected including, but not limited to, market conditions, availability of financing, future prices of gold, silver and other metals, currency rate fluctuations, high inflation and interest rates, actual results of production, exploration and development activities, actual resource grades and recoveries of silver, gold and other metals, availability of third party mineralized material for processing, unanticipated geological or structural formations and characteristics, geopolitical conflicts including wars, environmental risks, operating risks, accidents, labor issues, equipment or personnel delays, delays in obtaining governmental or regulatory approvals and permits, inadequate insurance, and other risks in the mining industry. There are no assurances that GSilver will be able to successfully discover and mine sufficient quantities of high grade mineral resources or other material at El Cubo, VMC, San Ignacio and Topia (including at Topia buying and processing ore from contractors) for processing at its existing mills to increase production, tonnage milled and recovery rates of gold, silver, and other metals in the amounts, grades, recoveries, costs and timetable anticipated. In addition, GSilver’s decision to process mineral resources and other material from El Cubo, VMC, San Ignacio and Topia is not based on a feasibility study of mineral reserves demonstrating economic and technical viability and therefore is subject to increased uncertainty and risk of failure, both economically and technically. Mineral resources and mineralized material that are not mineral reserves do not have demonstrated economic viability, are considered too speculative geologically to have economic considerations applied to them, and may be materially affected by environmental, permitting, legal, title, socio-political, marketing, and other relevant issues. There are no assurances that the Company’s projected production of silver, gold and other metals or the 2023 PEA will be realized. In addition, there are no assurances that the Company will meet its production forecasts or generate the anticipated cash flows from operations to satisfy its scheduled debt payments or other liabilities when due or meet financial covenants to which the Company is subject or to fund its exploration programs and corporate initiatives as planned. There is also uncertainty about the continued spread and severity of COVID-19, the ongoing war in Ukraine and high inflation and interest rates and the impact they will have on the Company’s operations, supply chains, ability to access mining projects or procure equipment, supplies, contractors and other personnel on a timely basis or at all and economic activity in general. Accordingly, readers should not place undue reliance on forward-looking statements or information. All forward-looking statements and information made in this news release are qualified by these cautionary statements and those in our continuous disclosure filings available on SEDAR at www.sedar.com including the Company’s most recently filed annual information form. These forward-looking statements and information are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required by law.

SOURCE: Guanajuato Silver Company Ltd.

View the original press release on accesswire.com

• Offer document published following approval by BaFin.
• Acceptance period commences today and ends on February 16, 2024; there will be no additional acceptance period.
• Opportunity for all CropEnergies shareholders to tender their shares at an attractive cash consideration of € 11.50 per share, representing a premium of around 36.9 % on the volume-weighted average price during the last six months preceding the publication of the decision to launch the delisting tender offer.
• Delisting tender offer is not subject to any closing conditions
• Delisting holds potential for improving liquidity and a revaluation of the Südzucker shares from which shareholders of CropEnergies can benefit through a re-investment in Südzucker.
• CropEnergies remains a strong independent pillar of the Südzucker Group.
• Executive board of CropEnergies supports delisting.

MANNHEIM, GERMANY / ACCESSWIRE / January 17, 2024 / Südzucker AG ("Südzucker") announces the publication of the offer document for the public delisting tender offer to all shareholders of CropEnergies AG ("CropEnergies") for the acquisition of all outstanding shares not already directly held by Südzucker, following the approval by the German Federal Financial Supervisory Authority ("BaFin"). Both companies signed a delisting agreement in this matter on December 19, 2023. Südzucker currently holds around 79.8 % of the share capital in CropEnergies.

The acceptance period begins today and ends at midnight (CET) on February 16, 2024.

CropEnergies shareholders can accept the delisting tender offer by tendering their shares at an offer price of € 11.50 per share. The offer price corresponds to a premium of approximately 36.9 % on the volume-weighted average price of the last six months preceding the publication of the decision to launch the delisting tender offer and a premium of around 69.4 % on the last Xetra® closing price of December 18, 2023, i.e. the closing price on the last day prior to the publication of the decision to launch the delisting tender offer.

CropEnergies shareholders who wish to accept the delisting tender offer must promptly contact their respective custodian bank or any other securities services company where their CropEnergies shares are being held. As announced on December 19, 2023, the delisting of CropEnergies is a logical step towards a more defined capital market profile of the Südzucker Group. The delisting creates additional potential for improving liquidity and a revaluation of the Südzucker shares. The delisting will enable CropEnergies to develop its strategic projects within the Südzucker Group with a focus on bio-based chemicals in a more focused manner. CropEnergies remains a strong independent pillar of the Südzucker Group.

The executive board of CropEnergies has undertaken, subject to customary reservations, to support a delisting and apply for revocation of the admission of all CropEnergies shares to trading on the regulated market of the Frankfurt Stock Exchange during the acceptance period. The executive board and supervisory board of CropEnergies will also publish a joint reasoned opinion on the delisting tender offer during the acceptance period.

Dr Niels Pörksen, CEO of Südzucker, says: "We would like to encourage all CropEnergies shareholders to accept our attractive offer before their shares are delisted from the regulated market. Shareholders of CropEnergies can also benefit from the future bundled value potential of the entire Südzucker-Group through a re-investment in Südzucker shares. The delisting will create capacities that we will utilise to accelerate the implementation of our ‘Strategy 2026 PLUS’. CropEnergies will increasingly focus on the growth topics of biobased chemicals."

The delisting tender offer will not be extended (unless required by law) and is not subject to any conditions. The delisting of the CropEnergies shares from the regulated market is expected to become effective after the expiry of the acceptance period of the delisting tender offer by the end of February 2024. The offer document and a non-binding English translation, alongside other information regarding the delisting tender offer, are available at www.powerofplants-offer.com. In addition, a shareholder hotline has been set up, which shareholders can call on 0080008250941 (inside Germany) or +44 207 2930434 (outside Germany, hosted in German) or +44 207 2930434 (outside Germany, hosted in English) if they have any questions.

Copies of the offer document are also available free of charge from the Delisting Acquisition Offer Settlement Agent: Deutsche Bank Aktiengesellschaft, TAS, Post-IPO Services, Taunusanlage 12, 60325 Frankfurt am Main, Germany. (Order for dispatch of the offer document by fax to +49 69 910 38794 or e-mail to dct.tender-offers@db.com, stating a complete postal address).

Important notice

This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of CropEnergies AG nor an offer or recommendation to purchase shares of Südzucker AG. The definitive terms of the delisting tender offer, as well as further provisions concerning the delisting tender offer, are set out in the offer document the publication of which has been approved by the German Federal Financial Supervisory Authority (BaFin). Investors and holders of shares in CropEnergies AG are strongly advised to read the offer document and all other relevant documents regarding the delisting tender offer, since they contain important information.

The delisting tender offer has been published exclusively under the laws of the Federal Republic of Germany, in particular in accordance with the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz) and the German Stock Exchange Act (Börsengesetz), as well as certain applicable provisions of the U.S. Securities Exchange Act. The documentation relating to the delisting tender offer is or will be available at www.powerofplants-offer.com. Any contract that is concluded on the basis of the delisting tender offer will be exclusively governed by the laws of the Federal Republic of Germany and is to be interpreted in accordance with such laws.

To the extent permissible under applicable law or regulation, and in accordance with German market practice, Südzucker AG, its affiliates or its brokers may purchase, or conclude agreements to purchase, shares of CropEnergies AG, directly or indirectly, outside of the scope of the delisting tender offer during or after the period in which the offer remains open for acceptance. This also applies to other securities which are directly convertible into, exchangeable for, or exercisable for shares of CropEnergies AG. These purchases may be completed via the stock exchange at market prices or outside the stock exchange at negotiated conditions. Any information on such purchases will be disclosed as required by law or regulation in Germany or any other relevant jurisdiction and on www.powerofplants-offer.com.

Südzucker AG
Maximilianstraße 10
68165 Mannheim, Germany

Financial press:

Dr Dominik Risser
Phone: +49 621 421-205
public.relations@suedzucker.de

Investor Relations:

Nikolai Baltruschat
Phone: +49 621 421-240
investor.relations@suedzucker.de

About the Südzucker Group

Südzucker is a major player in the food industry with its sugar, special products, starch and fruit segments, and Europe’s leading ethanol producer with its CropEnergies segment.

In the traditional sugar business, the group is Europe’s number one supplier of sugar products, with 23 sugar factories and two refineries, extending from France in the west via Belgium, Germany and Austria, through to Poland, the Czech Republic, Slovakia, Romania, Hungary, Bosnia, and Moldova in the east. The special products segment, with its consumer-oriented functional ingredients for food and animal feed (BENEO), chilled/frozen products (Freiberger) and portion packs (PortionPack Group), operates in dynamic growth markets. Südzucker’s CropEnergies segment is Europe’s leading producer of renewable ethanol, with production sites in Germany, Belgium, France and Great Britain. Other products in this segment are protein food and animal feed products as well as biogenic carbon dioxide. The starch segment comprises AGRANA’s starch and ethanol activities. The group’s fruit segment operates globally, is the world market leader for fruit preparations and is a leading supplier of fruit juice concentrates in Europe.

In 2022/23, the group employed about 18.300 persons and generated revenues of about EUR 9.5 billion.

About the CropEnergies AG

Sustainable, renewable products made from biomass – that is what CropEnergies stands for. Our products contribute to a climate-friendly world and ensure that fossil carbons remain in the ground permanently and do not continue to drive climate change.

Founded in Mannheim in 2006, the member of the Südzucker Group is the leading European producer of renewable ethanol. With a production capacity of 1.3 million m³ of ethanol per year, CropEnergies produces neutral alcohol as well as technical alcohol (ethanol) for a wide range of applications at locations in Germany, Belgium, the UK, and France: Sustainably produced ethanol as a petrol substitute is an answer to the future challenges of climate-friendly energy supply in the transport sector. Thanks to highly efficient production plants, our ethanol reduces CO₂ emissions by an average of more than 70 percent across the entire value chain compared to fossil fuel. Our high-quality alcohol is also used in beverage production, cosmetics, pharmaceutical applications, for example as a basis for disinfectants, or as a raw material for innovative biochemicals.

Equally important are the resulting protein food and animal feed products as a sustainable regional alternative to emission-intensive protein imports from overseas, as well as biogenic carbon dioxide. It is used in beverage production, among other things, and will be a valuable raw material for a wide range of applications in transport and industry in the future. Thus, all raw material components are utilised in our circular economy.

SOURCE: Südzucker AG

View the original press release on accesswire.com

SAN JOSE, CA / ACCESSWIRE / January 17, 2024 / Avidbank Holdings, Inc. (OTC PINK:AVBH), a bank holding company and the parent company of Avidbank, is pleased to announce that James Deutsch has joined the Board of Directors. Mr. Deutsch brings over 40 years of banking experience to the Board.

Mr. Deutsch will be replacing Mr. Roxy Rapp who retired as a longstanding director on Avidbank’s Board at the end of 2023.

"First, I want to thank Roxy for his 17 years of commitment and service to our board. Roxy has contributed on so many levels in so many different situations over the years. His real estate expertise, network, as well as his financial commitment have been invaluable in our progress. Roxy’s presence, insight and constructive personality will be missed in our boardroom. At the same time, we are looking forward to Jim’s contributions to the board," noted Mark Mordell, Chairman and Chief Executive Officer.

Mr. Deutsch is a partner in Patriot Financial Partners, a private equity firm based in Radnor, Pennsylvania. Prior to joining Patriot in 2021, Mr. Deutsch served as President, CEO, and Founder of Team Capital Bank, a privately held institution headquartered in Bethlehem, Pennsylvania. Before Team Capital, he spent over 25 years with Commerce Bank, Brown Brothers Harriman, and Summit Bank. At those banks, he held various management positions in commercial banking, investment banking, and corporate finance.

At Patriot, Mr. Deutsch is a member of the Investment Committee, and he also has responsibility for new investment opportunities. He has served on the Board of Directors of more than 10 banks ranging in size from $1 billion to $30 billion in assets. Outside of Patriot, Mr. Deutsch has served on the boards of many not-for-profit agencies and served as Chair on several of those including the State Theatre, Valley Youth House, and Minsi Trails Boy Scouts. Mr. Deutsch received his BS in Finance and his MBA from Lehigh University.

"We are pleased to welcome Jim to our board. For years, Jim and his firm have been one of our most significant and supportive investors. His operational experience will be accretive to our board and mission," said Mr. Mordell.

"I am pleased and honored to be joining the other directors on the board of Avidbank. The management of Avidbank has done a great job of building a unique franchise and I look forward to doing what I can to assist and execute on their future growth strategies," Mr. Deutsch stated.

In other board news, Ms. Henchy Enden has resigned from the board due to internal requirements of a new position she has recently taken with a global investment management firm.

"I am disappointed that Henchy had to resign after such a short tenure on our board. She has been a great asset to us over the past eighteen months. That being said, I fully understand her situation and am in support of her and her future endeavors. I thank Henchy for her contribution and wish her the very best in her new role," said Mr. Mordell.

About Avidbank

Avidbank Holdings, Inc. (OTC PINK:AVBH), headquartered in San Jose, California, offers innovative financial solutions and services. We specialize in commercial & industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, fund finance, and real estate construction and commercial real estate lending. Avidbank provides a different approach to banking. We do what we say.

Contact:

Patrick Oakes
Executive Vice President and Chief Financial Officer
408-200-7390
IR@avidbank.com

SOURCE: Avidbank Holdings, Inc.

View the original press release on accesswire.com

• UTILITY has received a Prescription Drug User Fee Act (PDUFA) target action date of April 24, 2024
• FDA granted Qualified Infectious Disease Product (QIDP) designation for PIVYA in 2018, which provides an additional 5 years of data exclusivity upon approval

LONDON, UK / ACCESSWIRE / January 17, 2024 / UTILITY therapeutics Ltd., a biotechnology company focused on the development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTIs) in the U.S., today announced a private financing led by the AMR Action Fund. In addition, UTILITY announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for PIVYA (pivmecillinam) for the treatment of uncomplicated UTIs (uUTI).

The FDA granted Priority Review of the NDA with a Prescription Drug User Fee Act (PDUFA) target action date of April 24, 2024.

Pivmecillinam is a European-approved, oral prodrug of mecillinam. Pivmecillinam has a unique mechanism of action and targets penicillin binding protein-2 (PBP-2) in the cell wall of gram-negative bacteria. UTILITY has received the FDA’s qualified infectious disease product (QIDP) designation for pivmecillinam for the treatment of uUTI. The FDA’s QIDP designation is for antibacterial and antifungal drug candidates intended to treat serious or life-threatening infections, and it provides an additional five years of market exclusivity.

"The number of safe, effective antibiotics that clinicians have at their disposal continues to dwindle in the face of rising rates of antimicrobial resistance," said AMR Action Fund CEO Henry Skinner, PhD. "Bringing pivmecillinam to the U.S. will give clinicians an important tool to help patients suffering from urinary tract infections and support efforts to enhance global access to this drug."

"We are grateful to the AMR Action Fund for its leadership and support to bring this much-needed antibiotic to the US market for uUTI," said Tom Hadley, President and CEO of UTILITY therapeutics. "We believe that PIVYA can be utilized as a first-line therapy where many of the current therapeutic options are limited due to efficacy, safety, and/or rising rates of resistance. Given there has not been a new antibiotic approved in the U.S. for the treatment of uUTI in over 20 years, the priority review by the FDA for PIVYA is an important step to providing a new option to physicians and patients as antimicrobial resistance continues to rise."

"This unique mechanism leads to favorable stability against beta-lactamase hydrolysis compared to other penicillins. In more than 30 million courses of treatment administered across Europe, oral pivmecillinam has demonstrated strong clinical cure rates with no serious adverse events observed, while maintaining a low resistance rate of approximately 5%," said Professor Morten Sommer, co-founder of UTILITY.

About UTILITY therapeutics Ltd.

UTILITY has exclusive U.S. commercial rights to two European-approved antibiotics, pivmecillinam and mecillinam, for the treatment of urinary tract infections (UTI). Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases. Mecillinam, an intravenous (IV) formulation, is being developed as a first-line therapy for complicated UTI (cUTI) in the hospital setting.

UTILITY has received the FDA’s qualified infectious disease product (QIDP) designation for pivmecillinam for the treatment of uUTI, and IV mecillinam followed by oral pivmecillinam as step-down, carbapenem-sparing therapy for cUTI. This therapeutic regimen allows patients to complete their treatment outside of hospital and reduces the economic burden of cUTI to both patients and payers. The FDA’s QIDP designation is for antibacterial and antifungal drug candidates intended to treat serious or life-threatening infections, and provides an additional five years of market exclusivity and potentially includes Priority Review.

For additional information, please visit www.utilitytherapeutics.com.

Contact

Tom Hadley
Chief Executive Officer
Tel: +1 (973) 224-7272
info@utilitytherapeutics.com

SOURCE: Utility therapeutics Ltd.

View the original press release on accesswire.com

LOS ANGELES, CA / ACCESSWIRE / January 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against VNET Group, Inc. ("VNET" or "the Company") (NASDAQ:VNET) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between April 8, 2022 and February 15, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before February 26, 2024.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. GenTao Capital Limited ("GenTao") was experiencing financial difficulties that created a substantial risk that its creditors would acquire its significant overship stake in VNET. The Company would issue newly created shares to GenTao owner Josh Sheng Chen, diluting the shares owned by investors. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about VNET, investors suffered damages.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE: The Schall Law Firm

View the original press release on accesswire.com

Statement Pursuant to Section 19(a) of the Investment Company Act of 1940

DENVER, CO / ACCESSWIRE / January 17, 2024 / On January 17, 2024, the Reaves Utility Income Fund (NYSE American:UTG) (the "Fund"), a closed-end sector fund, paid a monthly distribution on its common stock of $0.19 per share to shareholders of record at the close of business on December 29, 2023.

The following table sets forth the estimated amount of the sources of distribution for purposes of Section 19 of the Investment Company Act of 1940, as amended, and the related rules adopted thereunder. In accordance with generally accepted accounting principles ("GAAP"), the Fund estimates the following percentages, of the total distribution amount per share, attributable to (i) current and prior fiscal year net investment income, (ii) net realized short-term capital gain, (iii) net realized long-term capital gain and (iv) return of capital or other capital source as a percentage of the total distribution amount. These percentages are disclosed for the current distribution as well as the fiscal year-to-date cumulative distribution amount per share for the Fund.

Current Distribution from:
	Per Share ($)	%
Net Investment Income	0.02392	12.59%
Net Realized Short-Term Capital Gain	0.00000	0.00%
Net Realized Long-Term Capital Gain	0.16608	87.41%
Return of Capital or other Capital Source	0.00000	0.00%
Total (per common share)	0.19000	100.00%
Fiscal Year-to-Date Cumulative
Distributions from:
	Per Share ($)	%
Net Investment Income	0.12587	22.08%
Net Realized Short-Term Capital Gain	0.00000	0.00%
Net Realized Long-Term Capital Gain	0.44413	77.92%
Return of Capital or other Capital Source	0.00000	0.00%
Total (per common share)	0.57000	100.00%

The timing and character of distributions for federal income tax purposes are determined in accordance with income tax regulations which may differ from GAAP. As such, all or a portion of this distribution may be reportable as taxable income on your 2023 federal income tax return. The final tax character of any distribution declared in 2023 will be determined in January 2024 and reported to you on IRS Form 1099-DIV.

The amounts and sources of distributions reported in this 19(a) Notice are only estimates and not for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

Presented below are return figures, based on the change in the Fund’s Net Asset Value per share ("NAV"), compared to the annualized distribution rate for this current distribution as a percentage of the NAV on the last day of the month prior to distribution record date.

Fund Performance & Distribution Information

Fiscal Year to Date (11/01/2023 through 12/31/2023)
Annualized Distribution Rate as a Percentage of NAV^	8.54%
Cumulative Distribution Rate on NAV^	2.14%
Cumulative Total Return on NAV*	11.16%
Average Annual Total Return on NAV for the 5 Year Period Ended 12/31/2023**	5.36%

^ Based on the Fund’s NAV as of December 31, 2023.

*Cumulative fiscal year-to-date return is based on the change in NAV including distributions paid and assuming reinvestment of these distributions for the period November 1, 2023 through December 31, 2023.

**The 5 year average annual total return is based on change in NAV including distributions paid and assuming reinvestment of these distributions and is through the last business day of the month prior to the month of the current distribution record date.

While the NAV performance may be indicative of the Fund’s investment performance, it does not measure the value of a shareholder’s investment in the Fund. The value of a shareholder’s investment in the Fund is determined by the Fund’s market price, which is based on the supply and demand for the Fund’s shares in the open market. Past performance does not guarantee future results. Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s Managed Distribution Plan.

Furthermore, the Board of Trustees reviews the amount of any potential distribution and the income, capital gain or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the financial market environment. The Fund’s distribution policy is subject to modification by the Board of Trustees at any time. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

Paralel Distributors LLC, FINRA Member Firm.

Contact info:
Website: https://www.utilityincomefund.com
Email: info@utilityincomefund.com

SOURCE: Reaves Utility Income Fund

View the original press release on accesswire.com

NGY combines the stability from its gold reserve and running of prospective business projects with the innovation of blockchain technology, heralding a new era in cryptocurrency investments.

GRAND CAYMAN, CAYMAN ISLANDS / ACCESSWIRE / January 17, 2024 / Nagaya is excited to announce the launch of Nagaya (NGY), a groundbreaking cryptocurrency that marries the timeless value of gold with the innovative potential of blockchain technology. NGY is now available for trading on the renowned LATOKEN exchange, offering investors a unique opportunity to be part of a cryptocurrency which intrinsic value derived from real gold reserve that will grow over time.

Nagaya’s hybrid nature as a digital asset with intrinsic value offers a blend of security and growth potential. With value of each NGY token supported by tangible gold reserve, investors are provided with a level of stability rarely seen in the cryptocurrency market. This approach addresses common concerns about the volatility and intangibility of digital currencies.

As the cryptocurrency market continues to evolve, NGY stands out as a pioneering solution that has won several awards. Available on LATOKEN, a leading digital asset trading platform, NGY offers accessibility to both seasoned traders and new investors looking for a more stable digital asset experience.

The global investment community is invited to explore the possibilities with NGY on LATOKEN. As they move forward, Nagaya is committed to continuous innovation and expanding our reach in the digital asset market, ensuring NGY remains at the forefront of the cryptocurrency evolution.

For further information, please visit Nagaya’s official website.
To trade Nagaya on LATOKEN, kindly visit LATOKEN

Follow Nagaya on Telegram to know more about the project.

Media Contact

Organization: LATOKEN
Contact Person: Faith Elenwo
Website: https://www.latoken.com
Email: ir@latoken.com
City: Grand Cayman
Country: Cayman Islands

SOURCE: LATOKEN

View the original press release on accesswire.com

RIYADH, SAUDI ARABIA – Media OutReach Newswire – 17 January 2024 – Valuable Capital Financial Company (VCFC), a brokerage firm licensed by the Capital Market Authority (22251-25), announced the official launch of its online trading app “Sahm”, a platform proprietary designed and developed specifically for investors in Saudi Arabia.

Sahm is currently debuting with a special introductory offer. The first 3,000 users who successfully open an account will enjoy 0 commissions for the Saudi Stock Market for 12 months, along with free real-time quotes of U.S. stock market. As part of this limited-time promotion, they will also receive 15 free Lucid Group stocks.

Moreover, the app will reward its top three users who successfully invite the highest number of people to open accounts with an iPhone 15 Pro Max 1TB. Existing users also have the opportunity to earn a reward of $50 worth of stocks for each requirement they meet. For more details, visit https://www.alsahm.com/activitiesr/pre-activity-new?urlType=1&lang=en-US&_scnl=1110765

Speaking at the launch event, Hadeel Bedeeri, General Manager of VCFC, stated, “Since the beginning, our product philosophy has always been to design an all-in-one, easy-to-use trading platform tailored for domestic investors. And now, Sahm is just a perfect example of integrating everything investors need into one app.”

Sahm’s comprehensiveness is demonstrated via all-in-one features including market quotes, company data, 24/7 news, investors education materials, and analysis tool. This integration helps the app stand out among other trading platforms, which often require users to switch frequently between multiple apps when making investment decisions.

According to VCFC, the app supports both Arabic and English, with a sleek, user-friendly UI design embedded with bundled functions, like a Shariah Compliant Stocks indicator, demonstrating a strong commitment to the local market. Furthermore, functions related to market information reach as deep as detailed listed company profiles, financial event calendar, analysis charts dynamics and key market statistics.

In October 2023, VCFC received licenses from the Capital Market Authority (CMA) to conduct Dealing, Advising, and Custody services in KSA, making it the first international online brokerage firm to provide online brokerage services in KSA. The company is also a registered member of the Saudi stock exchange, Tadawul, as well as its affiliates, the Securities Depository Center Company (Edaa) and the Securities Clearing Center Company (Muqassa).

Sahm app is now available for download on the iOS App Store, the Android Play Store, and Huawei AppGallery.

https://www.alsahm.com/

Fat Tuesday Makes a Splash on South Beach’s Collins Avenue: Iconic Frozen Cocktail Brand Returns to the Heart of Miami’s Historic Art Deco District.

MIAMI BEACH, FL / ACCESSWIRE / January 17, 2024 / Fat Tuesday, the iconic brand and home of the original frozen cocktails and the famous 190 Octane® Daiquiri, is delighted to announce the grand opening of its latest store at 635 Collins Avenue in South Beach on January 20th, 2024. The new location, situated in the historic street of art deco, neon lights, and sandy beaches, marks a triumphant return to the vibrant South Beach scene.

The opening of Fat Tuesday on Collins Avenue is a celebration of Miami’s dynamic community, as the brand brings its signature frozen cocktails to the iconic street. The deco-inspired architecture, infused with the unmistakable Fat Tuesday flair, welcomes patrons from near and far to savor the best-frozen cocktails in the U.S. and Mexico. Patrons at the grand opening party can enjoy the special promotion of 50% off Daq Cup.

Founded in New Orleans in 1984, Fat Tuesday has become the premier destination for frozen beverages. The brand’s newest location within the renowned Metropole Hotel pays homage to Miami Beach’s cultural heritage, featuring an Art Deco ambiance, lounge-style setting, and an outdoor neon-lit terrazzo space. The Metropole Hotel, originally built in 1940, is a testament to the Art Deco style with Streamlined Moderne influences in the Ocean/Collins Avenue Historic District.

Co-CEO Kevin Higgins says "Bringing our famous frozen cocktails to the iconic Collins Avenue is our way of celebrating Miami’s vibrant community, and what better place to enjoy a good time with even better drinks?"

South Beach, dating back to the 1870s, has been a historic hub and a haven for travelers seeking its lively atmosphere. The return of Fat Tuesday to this iconic locale is not just a store opening; it’s a revival of the brand’s connection with the local community and a contribution to the vibrant South Beach scene. The original Fat Tuesday was known as both locals’ and tourists’ favorite place in the area.

Known for its vibrant cocktails, fire flavors, delectable bites, good music, and energetic vibes, Fat Tuesday is where the party begins. The reopening of Fat Tuesday South Beach is an opportunity to create new memories, be part of a storied legacy, and let the good times roll.

About Fat Tuesday

For nearly 40 years, Fat Tuesday has been serving frozen beverage enthusiasts, growing from a local, family-owned New Orleans business, to becoming the largest business in the United States specializing in frozen beverages and being known as an international frozen cocktail bar. With 56 company-owned locations and 23 franchised locations which are predominantly located in warm geographies, tourist destinations, entertainment districts, and outdoor malls, Fat Tuesday continues to be a trailblazer in the frozen beverage industry.

Guests are invited to join the celebration and share their experiences using the hashtags #fattuesdays on social media. Stay updated on the latest happenings by following Fat Tuesday on Instagram and Facebook.

For more information about Fat Tuesday, please visit www.fattuesday.com.

Media Contact:

Kevin Higgins
Marketing@fat-tuesday.com
PHONE NUMBER- 504-831-9415

SOURCE: Fat Tuesday

View the original press release on accesswire.com

PALO ALTO, CA / ACCESSWIRE / January 17, 2024 / Bioz, Inc., a leading Silicon Valley-based AI software company committed to advancing scientific discovery, is excited to announce its partnership with Innovative Research. Innovative Research is a leading supplier of lab reagents, including plasma, serum, tissues, and proteins. The company’s impressive portfolio of over 65,000 high-quality human and animal biologicals has been cited in tens of thousands of scientific publications.

This new partnership supports Innovative Research’s customers by bringing real-time product application data directly to its product webpages in the form of interactive digital web widgets called Bioz Badges. These widgets display detailed structured product information from journal publications, including text snippets, images, tables, and figure legends from scientific articles that mention Innovative Research’s products. These widgets also include an objective Bioz Stars rating that highlights each product’s track record of success in past scientific research. The rating is calculated by algorithmically analyzing a diverse set of parameters, including the number of product mentions, article publication date, and journal impact factor, among others.

"With such an impressive volume of citation data in the literature, we are thrilled to be working with Innovative Research," said Dr. Karin Lachmi, CRO and co-founder of Bioz. Dr. Lachmi added that "Innovative Research’s products have a proven track record of success in scientific discovery, with Bioz Badges being the most effective way to highlight this success for the benefit of researchers."

"Innovative Research is excited to partner with Bioz to bring scientific peer-reviewed journal publications that reference our products to our product webpages as a new service to our customers," said Wendy Wise, Vice President of Sales and Marketing at Innovative Research, adding that, "Bioz Badges are an incredibly beneficial tool for our customers to efficiently review our publication data for greater product validation."

About Bioz, Inc.

Bioz is the world’s most advanced AI search engine for life science experimentation, with evidence-based product ratings and recommendations to guide biopharma and academic scientists toward the most-validated products to use in their experiments, which accelerates research toward new discoveries. Bioz solutions also include Badges and Content Hubs, web-based widgets, that are placed on product supplier websites to increase user engagement and sales conversion.

Helpful Links

• Bioz
• Bioz Badges
• Bioz Stars
• Innovative Research

To learn more about the Bioz Partner Program, please reach out to info@bioz.com.

Contact Information

Daniel Levitt
CEO
pr@bioz.com

Wendy Wise
Vice President of Sales and Marketing
wwise@innov-research.com

SOURCE: Bioz, Inc.

View the original press release on newswire.com.

MESQUITE, NV / ACCESSWIRE / January 17, 2024 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor – the #1 patient-rated medical cannabis telemedicine service – now offers its online medical cannabis card service to patients in the state of West Virginia. "Our trusted telemedicine portal is ready to provide West Virginia medical cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor" said PrestoDoctor COO Rob Tankson.

Founded in 2015, PrestoDoctor has provided experienced and compassionate telemedicine care to more than 100,000 patients in thirteen states and is pleased to begin offering the same quality of service to patients in West Virginia.

"West Virginia should produce substantial appointments and increasing revenues for PrestoDoctor, and as medical cannabis continues to be available in more states, PrestoDoctor will be seeking to help those patients by safely connecting them to doctors from the comfort of their own home through PrestoDoctor’s proprietary portal" stated Cannabis Sativa CEO David Tobias.

About PrestoDoctor

PrestoDoctor is rated the #1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, Illinois, Iowa, Texas, Louisiana, Ohio, Arkansas, and now West Virginia. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor maintains the highest customer satisfaction rating for any telemedicine service online with over 21,000 5-star reviews.

About Cannabis Sativa, Inc.

Cannabis Sativa, Inc. ("CBDS") is engaged in telehealth, and the licensing of cannabis-related intellectual property, marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes and operates subsidiary PrestoDoctor®.

Forward-Looking Statements

This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. No assurances are, or can be given, that the parties will enter into a definitive merger agreement for any potential strategic acquisition, or that if such agreement is entered into, that the transaction would close, if at all, on the terms set forth in this release, or that the merged acquired business would be successful. Certain conditions to any closing of a potential merger acquisition would likely be outside of our control. The Company assumes no obligation to update any forward-looking statement to reflect any event or circumstance that may arise after the date of this release.

Contact Information:

(702) 762-3123
cbds.com

SOURCE: Cannabis Sativa, Inc.

View the original press release on accesswire.com